Catalyst Pharmaceuticals Announces Second Quarter 2015 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Catalyst Pharmaceuticals Announces Second Quarter 2015 Financial Results and Provides Corporate Update

Piper Jaffray Sees 'Transformational' Next 12 Months for Catalyst Pharmaceutical (CPRX)

August 11, 2015 11:05 AM EDT

Piper Jaffray analyst Charles Duncan reiterated an Overweight rating and $7 price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) after the company 2Q15 financials and a pipeline update, ending with $67.4M in cash.

"These resources should fully fund operations through Firdapse NDA approval and... More

Catyalyst Pharma (CPRX) Tops Q2 EPS by 2c

August 10, 2015 4:31 PM EDT

Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

... More